Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C3888018
Disease: Congenital Hyperinsulinism
Congenital Hyperinsulinism
0.200 GeneticVariation disease BEFREE A rare case of congenital hyperinsulinism (CHI) due to dual genetic aetiology involving HNF4A and ABCC8. 30730840 2019
CUI: C3888018
Disease: Congenital Hyperinsulinism
Congenital Hyperinsulinism
0.200 GeneticVariation disease BEFREE Nevertheless, the HNF4A gene testing may be considered in selected CHI cases with glycogenosis-like phenotype prior WES analysis. 28242437 2017
CUI: C3888018
Disease: Congenital Hyperinsulinism
Congenital Hyperinsulinism
0.200 GeneticVariation disease BEFREE Congenital hyperinsulinism can also be associated with mutations in the HNF4A gene. 27552834 2016
CUI: C3888018
Disease: Congenital Hyperinsulinism
Congenital Hyperinsulinism
0.200 Biomarker disease BEFREE Two patients with HNF4A-related congenital hyperinsulinism and renal tubular dysfunction: A clinical variation which includes transient hepatic dysfunction. 25819479 2015
CUI: C3888018
Disease: Congenital Hyperinsulinism
Congenital Hyperinsulinism
0.200 GeneticVariation disease BEFREE We report six patients heterozygous for the p.R76W HNF4A mutation who have Fanconi syndrome and nephrocalcinosis in addition to neonatal hyperinsulinism and macrosomia. 24285859 2014
CUI: C3888018
Disease: Congenital Hyperinsulinism
Congenital Hyperinsulinism
0.200 GeneticVariation disease BEFREE Glutamate dehydrogenase-CHI is the second most common cause of CHI, while HNF4A and GCK are rare types of CHI in Chinese patients. 25008049 2014
CUI: C3888018
Disease: Congenital Hyperinsulinism
Congenital Hyperinsulinism
0.200 GeneticVariation disease BEFREE In this case series, we report three children with HNF4A mutations (two de novo) and diazoxide-responsive congenital hyperinsulinism, highlighting the potential for ongoing diazoxide requirement and the importance of screening for these mutations even in the absence of family history. 23796040 2014
CUI: C3888018
Disease: Congenital Hyperinsulinism
Congenital Hyperinsulinism
0.200 Biomarker disease BEFREE The HNF4A MODY phenotype has been expanded by the reports of macrosomia in ∼50% of babies, and more rarely, neonatal hyperinsulinemic hypoglycemia. 23348805 2013
CUI: C3888018
Disease: Congenital Hyperinsulinism
Congenital Hyperinsulinism
0.200 Biomarker disease BEFREE Mutations in GLUD1, HADH, GCK and HNF4A genes were sought in patients with diazoxide-responsive CHI with hyperammonaemia (GLUD1), raised 3-hydroxybutyrylcarnitine and/or consanguinity (HADH), positive family history (GCK) or when CHI was diagnosed within the first week of life (HNF4A). 23345197 2013
CUI: C3888018
Disease: Congenital Hyperinsulinism
Congenital Hyperinsulinism
0.200 GeneticVariation disease BEFREE Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A. 22802087 2012
CUI: C3888018
Disease: Congenital Hyperinsulinism
Congenital Hyperinsulinism
0.200 Biomarker disease BEFREE Unlike HNF4-MODY where fetal macrosomia and early postnatal hyperinsulinemic hypoglycemia have been reported, history of transient insulin overproduction has not yet been recognized in individuals with HNF1A-MODY. 21648289 2011
CUI: C3888018
Disease: Congenital Hyperinsulinism
Congenital Hyperinsulinism
0.200 GeneticVariation disease BEFREE Hepatocyte nuclear factor 4α gene mutation associated with familial neonatal hyperinsulinism and maturity-onset diabetes of the young. 21353246 2011
CUI: C3888018
Disease: Congenital Hyperinsulinism
Congenital Hyperinsulinism
0.200 AlteredExpression disease BEFREE Activity and protein expression of GK-MODY and persistent hyperinsulinemic hypoglycemia of infancy (PHHI) mutants were studied in β-cell (MIN6) and non-β-cell (H4IIE) models. 22028181 2011
CUI: C3888018
Disease: Congenital Hyperinsulinism
Congenital Hyperinsulinism
0.200 GeneticVariation disease BEFREE HADH mutations are a relatively common cause of diazoxide-responsive HH with a frequency similar to that of GLUD1 and HNF4A mutations. 21252247 2011
CUI: C3888018
Disease: Congenital Hyperinsulinism
Congenital Hyperinsulinism
0.200 Biomarker disease BEFREE Unlike HNF4-MODY where fetal macrosomia and early postnatal hyperinsulinemic hypoglycemia have been reported, a history of transient insulin overproduction has not been recognized in individuals with HNF1A-MODY yet. 21823540 2011
CUI: C3888018
Disease: Congenital Hyperinsulinism
Congenital Hyperinsulinism
0.200 GeneticVariation disease BEFREE Rare forms of congenital hyperinsulinism (CHI) are caused by mutations in GLUD1 (encoding glutamate dehydrogenase), GCK (encoding glucokinase), HADH (encoding for L-3-hydroxyacyl-CoA dehydrogenase), SLC16A1 (encoding the monocarboxylat transporter 1), HNF4A (encoding hepatocyte nuclear factor 4α) or UCP2 (encoding mitochondrial uncoupling protein 2). 21186003 2011
CUI: C3888018
Disease: Congenital Hyperinsulinism
Congenital Hyperinsulinism
0.200 GeneticVariation disease BEFREE Congenital hyperinsulinism due to mutations in HNF4A and HADH. 20931292 2010
CUI: C3888018
Disease: Congenital Hyperinsulinism
Congenital Hyperinsulinism
0.200 Biomarker disease BEFREE We sequenced the ABCC8, KCNJ11, GCK, GLUD1, and/or HNF4A genes in 220 patients with HH responsive to diazoxide. 20164212 2010
CUI: C3888018
Disease: Congenital Hyperinsulinism
Congenital Hyperinsulinism
0.200 GeneticVariation disease BEFREE Recently, heterozygous mutations in the HNF4A gene were reported to cause transient hyperinsulinemic hypoglycemia associated with macrosomia. 18268044 2008
CUI: C3888018
Disease: Congenital Hyperinsulinism
Congenital Hyperinsulinism
0.200 GeneticVariation disease BEFREE HNF4alpha mutations paradoxically also cause in utero and neonatal hyperinsulinism, which later evolves to decreased glucose-induced secretion. 17923767 2007
CUI: C3888018
Disease: Congenital Hyperinsulinism
Congenital Hyperinsulinism
0.200 CausalMutation disease CLINVAR
CUI: C3888018
Disease: Congenital Hyperinsulinism
Congenital Hyperinsulinism
0.200 Biomarker disease HPO